| 12134636 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Yue-Mei Zhang +9 more |
2024-11-05 |
$502,780,000 |
| 11780900 |
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof |
Yue-Mei Zhang, Raul C. Camacho, Martin A. Case, Ellen Chi, Suzanne Edavettal +4 more |
2023-10-10 |
|
| 11767354 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more |
2023-09-26 |
$256,124,000 |
| 11732019 |
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Yue-Mei Zhang |
2023-08-22 |
$233,822,000 |
| 11591379 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more |
2023-02-28 |
$178,787,000 |
| 11401315 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more |
2022-08-02 |
$336,434,000 |
| 11230526 |
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors |
James C. Lanter, Mark J. Macielag, Michael Winters, Yue-Mei Zhang, Zhihua Sui |
2022-01-25 |
$277,663,000 |
| 10968265 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more |
2021-04-06 |
$118,870,000 |
| 10968264 |
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Yue-Mei Zhang |
2021-04-06 |
$118,870,000 |
| 10961293 |
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Yue-Mei Zhang |
2021-03-30 |
$81,035,000 |
| 10875902 |
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof |
Yue-Mei Zhang, Raul C. Camacho, Martin A. Case, Ellen Chi, Suzanne Edavettal +4 more |
2020-12-29 |
$133,092,000 |
| 10858413 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Yue-Mei Zhang +9 more |
2020-12-08 |
$82,354,000 |
| 10787495 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more |
2020-09-29 |
$182,772,000 |
| 10653673 |
Substituted imidazoles as N-type calcium channel blockers |
Ishtiyaque Ahmad, Rajagopal Bakthavatchalam, Sivaramakrishna Battula, Henricus Jacobus Maria Gijsen, Saravanan Vadivelu +1 more |
2020-05-19 |
$146,179,000 |
| 10640544 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more |
2020-05-05 |
$74,079,000 |
| 10428134 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more |
2019-10-01 |
$150,887,000 |
| 10077241 |
Tetrahydro-benzoimidazolyl modulators of TGR5 |
Xuqing Zhang, Zhihua Sui |
2018-09-18 |
$145,875,000 |
| 9974775 |
Substituted imidazoles as N-type calcium channel blockers |
Ishtiyaque Ahmad, Rajagopal Bakthavatchalam, Sivaramakrishna Battula, Henricus Jacobus Maria Gijsen, Saravanan Vadivelu +1 more |
2018-05-22 |
$61,691,000 |
| 9526731 |
Method of inhibiting C-KIT kinase |
Carl R. Illig, Shelley K. Ballentine, Jinsheng Chen, Sanath K. Meegalla, M. Jonathan Rudolph +4 more |
2016-12-27 |
$102,428,000 |
| 9452996 |
Inhibitors of c-fms kinase |
Carl R. Illig, Shelley K. Ballentine, Jinsheng Chen, Renee Louise Desjarlais, Sanath K. Meegalla +1 more |
2016-09-27 |
$137,302,000 |
| 9453002 |
Substituted imidazoles as N-type calcium channel blockers |
Ishtiyaque Ahmad, Rajagopal Bakthavatchalam, Sivaramakrishna Battula, Henricus Jacobus Maria Gijsen, Saravanan Vadivelu |
2016-09-27 |
$137,302,000 |
| 9434693 |
Substituted pyrazoles as N-type calcium channel blockers |
Nalin Subasinghe, Zhihua Sui, Christopher Flores |
2016-09-06 |
$91,731,000 |
| 9403804 |
Inhibitors of c-fms kinase |
Carl R. Illig, Shelley K. Ballentine, Jinsheng Chen, Renee Louise Desjarlais, Sanath K. Meegalla +1 more |
2016-08-02 |
$116,467,000 |
| 9394289 |
Inhibitors of c-fms kinase |
Carl R. Illig, Shelley K. Ballentine, Jinsheng Chen, Renee Louise Desjarlais, Sanath K. Meegalla +2 more |
2016-07-19 |
$162,393,000 |
| 9296726 |
Inhibitors of c-fms kinase |
Carl R. Illig, Shelley K. Ballentine, Jinsheng Chen, Renee Louise Desjarlais, Sanath K. Meegalla +1 more |
2016-03-29 |
$68,144,000 |
